Pictet Asset Management (Switzerland)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$10.6M	Buy	955,005 +260,368	+37%	+$3.63M	0.01%	605
2023 Q1	$9.33M	Buy	694,637 +448,002	+182%	+$7.75M	0.01%	631
2022 Q4	$3.05M	Buy	246,635 +63,529	+35%	+$900K	﹤0.01%	852
2022 Q3	$2.55M	Buy	183,106 +25,813	+16%	+$416K	﹤0.01%	880
2022 Q2	$2.17M	Buy	157,293 +14,768	+10%	+$236K	﹤0.01%	932
2022 Q1	$2.32M	Hold	142,525	–	–	﹤0.01%	946
2021 Q4	$2.32M	Buy	142,525 +36,202	+34%	+$610K	﹤0.01%	981
2021 Q3	$1.58M	Buy	+106,323	New	+$1.7M	﹤0.01%	1021

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

DCM

DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ICPT Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 37% in Q2 2023, buying an estimated $3.63M and bringing the position to 955,005 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #605.

Pictet Asset Management (Switzerland) first reported a position in ICPT in Q3 2021 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Pictet Asset Management (Switzerland) held 955,005 shares of Intercept Pharmaceuticals, Inc. worth $10.6M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 260,368 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $3.63M.
Intercept Pharmaceuticals, Inc. made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #605 holding.
Pictet Asset Management (Switzerland) first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2021 and has held it in 8 quarters since.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.